The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...
“According to S&S Insider, The Proteomics Market was valued at USD 30.61 billion in 2023 and is projected to grow to USD 96.35 billion by 2032, expanding at a compound annual growth rate (CAGR) of ...
EpiBiologics, a leader in tissue-selective extracellular protein degradation, will be presenting new data demonstrating the unique capabilities of its EpiTAC platform at the 16th Annual PEGS Europe ...
We are raising our fair value estimate for Waters to $340 per share, from $323 previously, based on cash flows generated since our last valuation update. Our valuation is based on discounted cash ...